A medical devices reimbursement rule proposed by CMS could lay the groundwork for innovative medicines to be covered by Medicare immediately after FDA approval. The proposed rule, which applies only to...
...peptide core with a sequence derived from GPIIIa’s... ...protein alpha 13 (GNA13); integrin β3 (GPIIIa; CD61... ...of Illinois at Chicago
G protein alpha 13 (GNA13)
Integrin beta(3) (GPIIIa) (CD61)
...royalties (see "Pliant to Flesh Out Fibrosis Pipeline After NASH Deal" ). PLN-74809, a dual CD51/CD29... ...CD51/CD29 - Integrin α V β 1
Sandi Wong, Assistant Editor
Pliant Therapeutics Inc.
Integrin alpha(V)beta(1) (CD51/CD29)
Insmed rose $8.34 (41%) to $28.88 on Monday, gaining $745 million in market cap, after its chronic lung inflammation therapy met the primary endpoint in a Phase II study. But the data, which included an...
...Two subsets -- one positive and one negative for FAP, and both expressing ACTA2 and CD29... ...2 smooth aorta muscle; BCMA (TNFRSF17; CD269) - Tumor necrosis factor receptor superfamily member 17; CD29... ...β
Institut National de la Sante et de la Recherche Medicale (INSERM)
Basilea Pharmaceutica Ltd.
Integrin beta(1) (CD29)